Fasting Comparative Bioavailability Study of 2 Meloxicam 15 mg Tablets in Healthy Volunteers Under Fasting Condition

NCT05125588 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Pharmacokinetics

Interventions

DRUG: Reumoxicam® 15 mg tablets (PJSC "Farmak", Ukraine)
DRUG: Movalis 15 mg tablets ("Boehringer Ingelheim Ellas A.E.", Greece)

Sponsor

Joint Stock Company "Farmak"